Scientific article
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
ContributorsGossec, Laure; Baraliakos, Xenofon; Kerschbaumer, Andreas; de Wit, Maarten; McInnes, Iain; Dougados, Maxime; Primdahl, Jette; McGonagle, Dennis G; Aletaha, Daniel; Balanescu, Andra; Balint, Peter V; Bertheussen, Heidi; Boehncke, Wolf-Henning; Burmester, Gerd R; Canete, Juan D; Damjanov, Nemanja S; Kragstrup, Tue Wenzel; Kvien, Tore K; Landewé, Robert B M; Lories, Rik Jozef Urbain; Marzo-Ortega, Helena; Poddubnyy, Denis; Rodrigues Manica, Santiago Andres; Schett, Georg; Veale, Douglas J; Van den Bosch, Filip E; van der Heijde, Désirée; Smolen, Josef S
Published inAnnals of the Rheumatic Diseases, vol. 79, no. 6, p. 700-712
Publication date2020
Abstract
Keywords
- Anti-Inflammatory Agents
- Non-Steroidal/therapeutic use
- Arthritis
- Psoriatic/drug therapy
- Biological Products/therapeutic use
- Consensus
- Consensus Development Conferences as Topic
- Decision Making
- Shared
- Europe
- Glucocorticoids/therapeutic use
- Humans
- Interleukin-12/antagonists & inhibitors
- Interleukin-17/antagonists & inhibitors
- Interleukin-23/antagonists & inhibitors
- Janus Kinase Inhibitors/therapeutic use
- Phosphodiesterase 4 Inhibitors/therapeutic use
- Societies
- Medical
- Synthetic Drugs/therapeutic use
- Systematic Reviews as Topic
- Tumor Necrosis Factor-alpha/antagonists & inhibitors
Affiliation entities
Research groups
Citation (ISO format)
GOSSEC, Laure et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. In: Annals of the Rheumatic Diseases, 2020, vol. 79, n° 6, p. 700–712. doi: 10.1136/annrheumdis-2020-217159
Main files (1)
Article (Published version)
Identifiers
- PID : unige:154813
- DOI : 10.1136/annrheumdis-2020-217159
- PMID : 32434812
Additional URL for this publicationhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286048/
Journal ISSN0003-4967
